Best Treatment Modality of Frozen Shoulder
Shoulder Adhesive Capsulitis ; Comparison Between Three Theraputic Approaches
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sohag, Egypt
- Sohag Faculty
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- gross limitation of passive shoulder movement
- pain interfering with daily activities
- painful restiction of active and passive movement of shoulder
Exclusion Criteria:
- presence of degenerative pathology
- fracture
- contraindication to steroid injection
- deformity affecting upper limb
- history of previous shoulder injection in the past 4 weeks
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Suprascapular nerve block
This group will include will under go suprascapularnerve block as following :10 ml of .5% bupivacaine and 2 ml of methylpradnisolon 40mg/ml
|
Under ultrasound guidance , local shoulder joint injection will be done
|
|
Active Comparator: Hydrodilatation of shoulder capsule
This group will undergo intraarticular hydrodilatation by injection of :first lidocaine10ml%followed by 1ml of methylprednisolon 40mg/ml and finally 20ml of .9
% sodium chloride slowly in the gleno humeral joint
|
Under ultrasound guidance , local shoulder joint injection will be done
|
|
Active Comparator: Hydrodilatation of shoulder interval
This group will undergo interval hydrodilatation by injection of :first mepivacaine 10ml folowed by 20ml of sterile water slowly in the shoulder interval
|
Under ultrasound guidance , local shoulder joint injection will be done
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement in range of motion of shoulder joint
Time Frame: 12 weeks efter intervention
|
Improvement will be measured by measuring active and passive range of motion
|
12 weeks efter intervention
|
|
Improvement in pain
Time Frame: 12 weeks after intervention
|
Improvement will be measured by VAS ( visual auditory assessment )
|
12 weeks after intervention
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Soh-Med-21-05-04
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.